Related Experiment Video
Updated: Oct 10, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a) in coronary heart disease: a case-control study
Insights
Elevated lipoprotein(a) levels are significantly higher in coronary heart disease patients compared to controls. This finding holds true for both younger and older individuals, indicating its importance in heart disease risk.
Area of Science:
- Cardiovascular Medicine
- Clinical Biochemistry
Background:
- Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
- Lipoprotein(a) [Lp(a)] is an emerging risk factor for atherosclerotic cardiovascular diseases.
- Understanding the role of Lp(a) in CHD is crucial for risk stratification and management.
Purpose of the Study:
- To investigate the association between lipoprotein(a) levels and coronary heart disease.
- To compare Lp(a) concentrations in newly diagnosed CHD patients versus healthy controls.
Main Methods:
- A case-control study involving 48 CHD patients and 23 controls.
- Clinical history and biochemical examinations were performed.
- Lipoprotein(a) levels were quantified using a latex-enhanced immunoturbidimetric method.
Main Results:
- No significant differences were observed in traditional risk factors like diabetes, hypertension, smoking, or dietary intake between cases and controls.
- Standard lipid parameters (cholesterol, LDL-C, HDL-C, triglycerides) and lipid ratios were similar between groups.
- Mean lipoprotein(a) levels were significantly higher in CHD patients (11.95 mg/dL) compared to controls (6.68 mg/dL) (p=0.041).
- Elevated Lp(a) was observed in CHD patients across all age groups, including those under and over 50 years.
- A higher prevalence of high Lp(a) levels (≥20 mg/dL) was noted in CHD patients (31.3%) versus controls (13.0%).
- The comprehensive lipid tetrad index, incorporating Lp(a), was also higher in CHD cases.
Conclusions:
- Lipoprotein(a) is significantly elevated in coronary heart disease patients, independent of traditional risk factors.
- Elevated Lp(a) levels are a significant marker in both younger and older CHD patients.
- Lipoprotein(a) may serve as an independent predictor of coronary heart disease risk.
Abstract:
To determine the significance of lipoprotein(a) levels in coronary heart disease patients, a case-control study was performed with 48 newly diagnosed coronary heart disease patients and 23 controls who were evaluated using clinical history and biochemical examination. Lipoprotein(a) was measured by quantitative latex-enhanced immunoturbidimetric method. Geometric means of biochemical parameters were obtained. Comprehensive lipid tetrad index was calculated using a previously validated formula. There was no significant difference in prevalence of diabetes, hypertension and smoking in cases and controls. Dietary intake of calories, fats, fatty acids and antioxidant vitamins was also similar. The levels of fasting glucose, cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides were not significantly different in cases and controls (p > 0.05). Low-density lipoprotein/high-density lipoprotein ratio (4.33 +/- 1.5 vs 4.29 +/- 1.8) and total cholesterol/high-density lipoprotein ratio (6.59 + 1.7 vs 6.69 +/- 2.2) were similar. The mean lipoprotein(a) levels were significantly greater in cases (11.95 +/- 2.8 mg/dL, range 1-102 mg/dL) as compared to controls (6.68 +/- 3.4 mg/dL, range 1-73 mg/dL) (t = 2.08, p = 0.041). As compared to controls, in coronary heart disease cases, mean lipoprotein(a) levels in patients upto 50 years (10.27 +/- 2.8 vs 7.27 +/- 3.4 mg/dL) as well as those over 50 years (12.99 +/- 2.9 vs 4.91 +/- 3.5 mg/dL) were significantly more (p < 0.05). Coronary heart disease patients had a slightly greater prevalence of high lipoprotein(a) levels, 20 mg/dL or more (31.3 vs 13.0%; chi 2 = 2.83, l-tailed p < 0.05). Comprehensive lipid tetrad index (total cholesterol x triglycerides x lipoprotein(a) divided by high-density lipoprotein cholesterol) was also slightly higher in cases (14688.2 +/- 3.6) than in controls (8358.2 +/- 4.3) (t = 1.68, 1-tailed p < 0.05). This study shows that lipoprotein(a) levels are significantly more in both younger and older coronary heart disease patients as compared to controls.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies